The DG Research workshop "From Systems Biology to Systems Medicine” report is now available. It is the unique opportunity to discover the 3 best practices and to anticipate the future European Research programs calls
The document summarizes the procurement of a robotic tool for CT guided tumor ablation and biopsy from funds under the Chief Minister's Comprehensive Health Insurance Scheme for use in radiology departments of government medical college hospitals. It details discussions that took place between relevant departments on the benefits of the robotic tool. It was concluded that the tool would improve procedures like biopsies and reduce their costs. The government approved the procurement of the robotic tool for 12 medical college hospitals at a total cost of Rs. 1.1 crore to be funded by the Chief Minister's insurance scheme funds.
1. The authors developed technologies to genetically engineer virulent phage banks that could rapidly detect and control emergent pathogenic bacteria.
2. Their approach involves modifying phage genes associated with host range using a technique called TAPE that introduces random mutations while preserving other gene regions, allowing for a wide diversity of variants.
3. They then recombinantly insert the modified genes into the genomes of wild-type phages using a technique called AB-Accus that reversibly interrupts the phage lytic cycle to allow for efficient recombination.
4. This allows production of large phage banks containing variants that could detect and destroy diverse gram-negative bacterial species, providing a flexible means to address emergent outbreaks.
PharmacoPsychiatry publishes the first invited review describing a productive vision of Systems Medicine that will change R&D organization and interactions between clinicians & researchers.
The invited review explains how the world\'s first explanation of the mechanisms of the Creutzfeldt-Jakob disease led to the discovery of a truly innovative psychiatric treatment
The document summarizes a workshop on applying systems biology approaches to medical research and practice. The workshop aimed to analyze the current state, identify opportunities and barriers, and recommend areas for collaboration. Participants discussed how systems biology could help clinical trials, redefine disease phenotypes, discover biomarkers, enable combinatorial therapies, and improve drug development. Key areas for future research include understanding chronic diseases through network analysis, combining personalized omics data with clinical information, and developing combinatorial drug screening. The major challenge is for systems biology to help transition to a predictive, personalized, preventive and participatory model of medicine.
About Pherecydes Pharma
Pherecydes Pharma SA specializes in the research and development of lytic bacteriophages
(or phages) for both therapeutic and diagnostic applications. The company provides
innovative and adaptable solutions to combat multi-resistant bacteria, through developing
mixtures of natural phages and their accelerated in vitro evolution. Pherecydes Pharma is
the only company currently that has been able to harness this evolution technology, allowing
a head start on any given bacterium.
Due to the unique knowledge of the company in the characterization and rapid isolation of
natural lytic phages, Pherecydes Pharma has developed a large bank of bacteriophage
mixtures for combating infections that are resistant to antibiotics, which have steadily
increased in number since the 1980s. In particular, it possesses the world’s largest
collection of phages against Escherichia coli and is also working on Pseudomonas and
Staphylococci, three bacteria that alone represent over 50% of known infections in
industrialized countries.
This document discusses proteome-based pathway modelling approaches for understanding psychiatric disorders like schizophrenia and major depressive disorder. It notes that these disorders involve complex interactions between neuronal and non-neuronal (glial) components across different scales. Gene expression data is limited and proteomics approaches using metabolic labelling and mass spectrometry are needed to provide quantitative protein dynamics data. This data can help identify dysfunctional pathways and biomarkers. Modelling approaches are then required to predict molecular and physiological consequences and experimentally test these. Spatially resolved proteomics using techniques like confocal microscopy could help map pathology within affected brain regions.
This document provides information about Bio-Modeling Systems SAS, including contact details and an overview of their services. It discusses the need to change the drug discovery paradigm to address issues like high failure rates and unreliable research. Bio-Modeling Systems provides a platform called CADITM Discovery that uses a mechanisms-based approach and principles like negative selection to model biological complexity and address uncertainties in scientific data. The goal is to improve medical research and validation processes to enhance patient health outcomes.
Prof Luigi Angrisani - Final program Brussels April 2014Luigi Angrisani
Il programma integrale del convegno svoltosi a Brussels ad aprile 2014, al quale ha partecipato Luigi Angrisani, nominato l'anno scorso Presidente dell'IFSO.
The document summarizes the procurement of a robotic tool for CT guided tumor ablation and biopsy from funds under the Chief Minister's Comprehensive Health Insurance Scheme for use in radiology departments of government medical college hospitals. It details discussions that took place between relevant departments on the benefits of the robotic tool. It was concluded that the tool would improve procedures like biopsies and reduce their costs. The government approved the procurement of the robotic tool for 12 medical college hospitals at a total cost of Rs. 1.1 crore to be funded by the Chief Minister's insurance scheme funds.
1. The authors developed technologies to genetically engineer virulent phage banks that could rapidly detect and control emergent pathogenic bacteria.
2. Their approach involves modifying phage genes associated with host range using a technique called TAPE that introduces random mutations while preserving other gene regions, allowing for a wide diversity of variants.
3. They then recombinantly insert the modified genes into the genomes of wild-type phages using a technique called AB-Accus that reversibly interrupts the phage lytic cycle to allow for efficient recombination.
4. This allows production of large phage banks containing variants that could detect and destroy diverse gram-negative bacterial species, providing a flexible means to address emergent outbreaks.
PharmacoPsychiatry publishes the first invited review describing a productive vision of Systems Medicine that will change R&D organization and interactions between clinicians & researchers.
The invited review explains how the world\'s first explanation of the mechanisms of the Creutzfeldt-Jakob disease led to the discovery of a truly innovative psychiatric treatment
The document summarizes a workshop on applying systems biology approaches to medical research and practice. The workshop aimed to analyze the current state, identify opportunities and barriers, and recommend areas for collaboration. Participants discussed how systems biology could help clinical trials, redefine disease phenotypes, discover biomarkers, enable combinatorial therapies, and improve drug development. Key areas for future research include understanding chronic diseases through network analysis, combining personalized omics data with clinical information, and developing combinatorial drug screening. The major challenge is for systems biology to help transition to a predictive, personalized, preventive and participatory model of medicine.
About Pherecydes Pharma
Pherecydes Pharma SA specializes in the research and development of lytic bacteriophages
(or phages) for both therapeutic and diagnostic applications. The company provides
innovative and adaptable solutions to combat multi-resistant bacteria, through developing
mixtures of natural phages and their accelerated in vitro evolution. Pherecydes Pharma is
the only company currently that has been able to harness this evolution technology, allowing
a head start on any given bacterium.
Due to the unique knowledge of the company in the characterization and rapid isolation of
natural lytic phages, Pherecydes Pharma has developed a large bank of bacteriophage
mixtures for combating infections that are resistant to antibiotics, which have steadily
increased in number since the 1980s. In particular, it possesses the world’s largest
collection of phages against Escherichia coli and is also working on Pseudomonas and
Staphylococci, three bacteria that alone represent over 50% of known infections in
industrialized countries.
This document discusses proteome-based pathway modelling approaches for understanding psychiatric disorders like schizophrenia and major depressive disorder. It notes that these disorders involve complex interactions between neuronal and non-neuronal (glial) components across different scales. Gene expression data is limited and proteomics approaches using metabolic labelling and mass spectrometry are needed to provide quantitative protein dynamics data. This data can help identify dysfunctional pathways and biomarkers. Modelling approaches are then required to predict molecular and physiological consequences and experimentally test these. Spatially resolved proteomics using techniques like confocal microscopy could help map pathology within affected brain regions.
This document provides information about Bio-Modeling Systems SAS, including contact details and an overview of their services. It discusses the need to change the drug discovery paradigm to address issues like high failure rates and unreliable research. Bio-Modeling Systems provides a platform called CADITM Discovery that uses a mechanisms-based approach and principles like negative selection to model biological complexity and address uncertainties in scientific data. The goal is to improve medical research and validation processes to enhance patient health outcomes.
Prof Luigi Angrisani - Final program Brussels April 2014Luigi Angrisani
Il programma integrale del convegno svoltosi a Brussels ad aprile 2014, al quale ha partecipato Luigi Angrisani, nominato l'anno scorso Presidente dell'IFSO.
This document outlines the agenda for a two-day training event on analytical chemistry techniques and their medical applications. Day 1 includes courses on gas chromatography-mass spectrometry (GC-MS), high-performance liquid chromatography (HPLC), HPLC-MS, and nuclear magnetic resonance (NMR) spectroscopy. Participants will also visit the facilities of the Institute of Chemistry of Cluj-Napoca. Day 2 focuses on applications of exhaled breath analysis for diagnosing diseases like tuberculosis and cancer, with presentations from researchers in Romania, Germany, Spain, and Italy. Talks will cover breath sensing technologies, biomarker detection, and portable sampling prototypes.
This document outlines the agenda for a two-day training event on analytical chemistry techniques and their medical applications. Day 1 includes courses on gas chromatography-mass spectrometry (GC-MS), high-performance liquid chromatography (HPLC), HPLC-MS, and nuclear magnetic resonance (NMR) spectroscopy. Participants will also visit the facilities of the Institute of Chemistry of Cluj-Napoca. Day 2 focuses on applications of exhaled breath analysis for diagnosing diseases like tuberculosis and cancer, with presentations from researchers in Romania, Germany, Spain, and Italy. Talks will cover breath sensing technologies, biomarker detection, and portable sampling prototypes.
This document outlines the schedule for the Botswana Health Sciences Student Symposium (BHSS) over two days. Day 1 includes panel discussions on priorities in healthcare like non-communicable diseases and HIV/AIDS, as well as health inequities and health informatics. There will also be roundtable discussions and a social event in the evening. Day 2 focuses on the next generation of healthcare professionals with panels on career development and youth empowerment. It concludes with a panel on research and breakout workshops to explore research areas, followed by a closing ceremony.
The document provides an agenda for the 2nd CUTEheart Workshop on Health Technology Assessment in Cardiovascular Disease held in Portugal on April 23rd, 2016. The workshop included sessions on international perspectives on health technology assessment in cardiovascular care, the main results and lessons from the CUTEheart project, and a round table discussion on implementing health technology assessment in Portugal. Speakers represented universities and research institutions from Portugal, the UK, USA, and Australia. The workshop provided an opportunity for stakeholders in cardiovascular health to discuss approaches to health technology assessment.
On 24 November 2017, the Donders Institute for Brain, Cognition and Behavior and i3B organize the networking event Neurovation to create neuroscience-driven solutions for current and future societal issues.
This document outlines the program for a two-day conference on cell therapy and regenerative medicine held in Nantes, France on September 8-9, 2016. The program included five sessions over the two days covering topics such as stem cell therapies, cell therapies for bone and joint repair, cell immunotherapy, stem cells for drug discovery and regenerative medicine, and roundtables on regulations and business models. There were over 30 presentations and talks given by researchers and industry professionals from France, the UK, US, Belgium, Spain, Canada, and other countries. Poster presentations and exhibitions were also part of the program, which concluded with closing remarks and looking ahead to the next conference in 2018.
World Nephrology Congress will be held in Paris, France during June 20-22, 2018. It will bring together world-class nephrologists, scientists and professors to discuss strategies for disease remediation for kidney in this nephrology congress. World Nephrology Congress is designed to provide a diverse and current education that will keep medical professionals up to date on issues affecting the diagnosis, treatment of kidney disorders and prevention.
Scientific Sessions
Nephrology
Clinical Nephrology
Pediatric Nephrology
Treatments in Nephrology
Nephrology Nursing
Diabetes and Hypertension
Renal Dialysis and Care
Renal Surgery
Kidney Cancer
Kidney Transplantation
For more details, kindly visit: https://www.meetingsint.com/nephrology-conferences/nephrology
Alcohol & Medication in Pregnancy Conference AgendaHannah Stockdale
This document outlines the agenda for a two-day conference on alcohol consumption during pregnancy and its potential consequences. Day 1 focuses on enhancing understanding of substance use in pregnancy through presentations and workshops. Day 2 focuses on research methodologies through keynote speeches and updates on current studies. The conference aims to raise knowledge on how alcohol and medications during pregnancy can impact health, and explores qualitative and quantitative research approaches. It is aimed at medical, nursing, psychology and sociology students and professionals with an interest in maternal and child health.
The document announces the 8th European Multidisciplinary Colorectal Cancer Congress (EMCCC) to be held on December 11-13, 2016 in Amsterdam. It provides information on registration deadlines, the scientific program including workshops on various topics related to colorectal cancer, and keynote speakers. The congress aims to facilitate multidisciplinary interaction and discussion among researchers and clinicians from different areas involved in colorectal cancer.
The slide presentation from PCORI'S Advisory Panel on Assessment of Prevention, Diagnosis, and Treatment Options April 28-29, 2014 meeting in Alexandria, VA.
Agenda slides and session slides lorentz workshop (3)George van Aken
This document contains the schedule and themes for a workshop on biophysics, biochemistry, and physiology of fat digestion held from September 16-20, 2013. The workshop covered 7 themes:
1) Controlled fat digestion and implications of fat in food
2) Biophysics of fat digestion
3) Controlling fat digestion and modeling fat digestion
4) In vitro modeling of digestive processes
5) Bioaccessibility and pharmacokinetics of non-triglyceride lipids
6) Cholesterol, a functional lipid
7) Designed food structures: Targets and Approaches
Each day consisted of lectures and sessions on the different themes with chairs and moderators leading the discussions.
8th National Pharmacy R&D Conference 2014Hasnain Zafar
The document outlines the program for a national pharmacy conference held from June 8-12, 2014. It details the schedule of events which includes workshops, presentations, plenary sessions, exhibitions and social events. On the first day, workshops will be held on topics such as pharmacy practice research, social media for research, and medical statistics. The main conference runs from June 10-12 with keynote speeches, oral and poster presentations on clinical pharmacy, pharmacy practice and other topics. Presentations are divided into sessions and special guest speakers will give plenary talks. Social events include welcome dinner, lunch symposiums and a gala dinner. The conference aims to promote quality research and discussions to improve patient and health system outcomes.
Klose lymphedema conference 2011 faculty and programklosetraining
We are honored to present Prof. Ethel Földi, MD as our Keynote Speaker. Prof. Földi is an internationally recognized authority on clinical lymphedema and lymphatic disorders. She serves as the Medical Director at the world-renowned Földi Clinic, specializing in the diagnosis and treatment of patients with lymphedema. Currently, Prof. Földi is the president of the Society of German-speaking lymphologists and a member of the International Advisory Committee to the National Lymphedema Network (NLN). She is also a past-President of the International Society of Lymphology (ISL).
This document outlines the program for a two-day cell therapy conference with sessions on various applications of cell therapy including for heart disease, bone repair, immunotherapy, and drug discovery. Day 1 consists of sessions on cell therapy for heart disease, bone repair, and immunotherapy. Day 2 covers stem cells for drug discovery and roundtable discussions on business models and regulations in cell therapy. The program includes over 30 speaker presentations and poster sessions.
This document provides details on the organization of the 109th anniversary event of the Faculty of Medicine at Unair University. It will include 4 episodes discussing topics like healthcare entrepreneurship, international research collaboration, and medical tourism in Indonesia. Episodes will feature international and local speakers as well as panel discussions. The event will utilize a hybrid format with some speakers and attendees online and others offline. Precise schedules, speakers, and logistical details are provided for each episode. The budget outlines costs for coordination, speaker and moderator honorariums, venue, catering, and other expenses totaling over 173 million rupiah.
The document provides information about the 10th annual conference of the International Society for Pelviperineology (ISPP) being held from October 10-13, 2013 in Sydney, Australia. The conference will feature international and local speakers covering the latest developments in pelvic medicine and surgery. Events include advanced surgical skills workshops, debates, and presentations on topics such as pelvic organ prolapse, urinary incontinence, and fistula repair. Social events include a welcome reception, gala dinner with views of Sydney Harbour, and a Sydney Harbour cruise with luncheon. A post-conference cadaver workshop will also be held.
Workshop "Biomedical technologies at Skokovo. Opportunities and challenges"igorod
This document provides the preliminary program for the "Biomedical technologies at Skokovo. Opportunities and challenges" workshop being held on February 1-2, 2011 at the Ritz Carlton in Moscow. The workshop will consist of 5 sessions over the two days covering topics such as opportunities and challenges in biomedical technologies, interdisciplinary research, platform technologies, systems medicine, and moving biomedical research forward. Presentations will be given by over 30 professors and researchers from Russia, the United States, the United Kingdom, Germany, and Canada. The workshop will conclude with a round table discussion moderated by Chris Janssen.
8º Conferencia Internacional de Avances en Osteopatia Medicaguestac667c
This document provides the conference program for the 8th International Conference on Advances in Osteopathic Medicine hosted by the British College of Osteopathic Medicine in Milan, Italy from April 23rd to 25th, 2010. The conference includes oral presentations over three days on topics related to osteopathic research, treatment, and education. It also includes poster sessions, plenary sessions, and a conference dinner. Presentations will be organized into sessions led by chairs and will cover research on osteopathic treatments for various musculoskeletal conditions and systemic issues.
1. Bio-Modeling Systems is a French company that uses its proprietary CADITM Discovery platform to generate mechanistic models of diseases and their underlying biological mechanisms.
2. The company was founded in 2004 and has since led collaborations resulting in two therapeutic spin-offs in clinical trials and publications in peer-reviewed journals.
3. CADITM Discovery integrates human and artificial intelligence to address the complexity of biological mechanisms and unreliability of scientific publications in a novel discovery paradigm.
This document summarizes information about biopharma industry competitiveness in France. It discusses France's strengths in the biopharma sector including its ranking as the top region in Europe for pharmaceuticals, medtech, and public-sector research. It profiles the organization Adebiotech which is France's independent multidisciplinary biotechnology think-tank and represents various industrial and academic members. It also summarizes projects from companies in France including Bio-Modeling Systems, Pherecydes Pharma, Clean Cells, and their roles in developing novel therapies, conducting clinical trials, and manufacturing biopharmaceutical products.
More Related Content
Similar to Final Agenda Workshop Dg Research Ec Sys Med
This document outlines the agenda for a two-day training event on analytical chemistry techniques and their medical applications. Day 1 includes courses on gas chromatography-mass spectrometry (GC-MS), high-performance liquid chromatography (HPLC), HPLC-MS, and nuclear magnetic resonance (NMR) spectroscopy. Participants will also visit the facilities of the Institute of Chemistry of Cluj-Napoca. Day 2 focuses on applications of exhaled breath analysis for diagnosing diseases like tuberculosis and cancer, with presentations from researchers in Romania, Germany, Spain, and Italy. Talks will cover breath sensing technologies, biomarker detection, and portable sampling prototypes.
This document outlines the agenda for a two-day training event on analytical chemistry techniques and their medical applications. Day 1 includes courses on gas chromatography-mass spectrometry (GC-MS), high-performance liquid chromatography (HPLC), HPLC-MS, and nuclear magnetic resonance (NMR) spectroscopy. Participants will also visit the facilities of the Institute of Chemistry of Cluj-Napoca. Day 2 focuses on applications of exhaled breath analysis for diagnosing diseases like tuberculosis and cancer, with presentations from researchers in Romania, Germany, Spain, and Italy. Talks will cover breath sensing technologies, biomarker detection, and portable sampling prototypes.
This document outlines the schedule for the Botswana Health Sciences Student Symposium (BHSS) over two days. Day 1 includes panel discussions on priorities in healthcare like non-communicable diseases and HIV/AIDS, as well as health inequities and health informatics. There will also be roundtable discussions and a social event in the evening. Day 2 focuses on the next generation of healthcare professionals with panels on career development and youth empowerment. It concludes with a panel on research and breakout workshops to explore research areas, followed by a closing ceremony.
The document provides an agenda for the 2nd CUTEheart Workshop on Health Technology Assessment in Cardiovascular Disease held in Portugal on April 23rd, 2016. The workshop included sessions on international perspectives on health technology assessment in cardiovascular care, the main results and lessons from the CUTEheart project, and a round table discussion on implementing health technology assessment in Portugal. Speakers represented universities and research institutions from Portugal, the UK, USA, and Australia. The workshop provided an opportunity for stakeholders in cardiovascular health to discuss approaches to health technology assessment.
On 24 November 2017, the Donders Institute for Brain, Cognition and Behavior and i3B organize the networking event Neurovation to create neuroscience-driven solutions for current and future societal issues.
This document outlines the program for a two-day conference on cell therapy and regenerative medicine held in Nantes, France on September 8-9, 2016. The program included five sessions over the two days covering topics such as stem cell therapies, cell therapies for bone and joint repair, cell immunotherapy, stem cells for drug discovery and regenerative medicine, and roundtables on regulations and business models. There were over 30 presentations and talks given by researchers and industry professionals from France, the UK, US, Belgium, Spain, Canada, and other countries. Poster presentations and exhibitions were also part of the program, which concluded with closing remarks and looking ahead to the next conference in 2018.
World Nephrology Congress will be held in Paris, France during June 20-22, 2018. It will bring together world-class nephrologists, scientists and professors to discuss strategies for disease remediation for kidney in this nephrology congress. World Nephrology Congress is designed to provide a diverse and current education that will keep medical professionals up to date on issues affecting the diagnosis, treatment of kidney disorders and prevention.
Scientific Sessions
Nephrology
Clinical Nephrology
Pediatric Nephrology
Treatments in Nephrology
Nephrology Nursing
Diabetes and Hypertension
Renal Dialysis and Care
Renal Surgery
Kidney Cancer
Kidney Transplantation
For more details, kindly visit: https://www.meetingsint.com/nephrology-conferences/nephrology
Alcohol & Medication in Pregnancy Conference AgendaHannah Stockdale
This document outlines the agenda for a two-day conference on alcohol consumption during pregnancy and its potential consequences. Day 1 focuses on enhancing understanding of substance use in pregnancy through presentations and workshops. Day 2 focuses on research methodologies through keynote speeches and updates on current studies. The conference aims to raise knowledge on how alcohol and medications during pregnancy can impact health, and explores qualitative and quantitative research approaches. It is aimed at medical, nursing, psychology and sociology students and professionals with an interest in maternal and child health.
The document announces the 8th European Multidisciplinary Colorectal Cancer Congress (EMCCC) to be held on December 11-13, 2016 in Amsterdam. It provides information on registration deadlines, the scientific program including workshops on various topics related to colorectal cancer, and keynote speakers. The congress aims to facilitate multidisciplinary interaction and discussion among researchers and clinicians from different areas involved in colorectal cancer.
The slide presentation from PCORI'S Advisory Panel on Assessment of Prevention, Diagnosis, and Treatment Options April 28-29, 2014 meeting in Alexandria, VA.
Agenda slides and session slides lorentz workshop (3)George van Aken
This document contains the schedule and themes for a workshop on biophysics, biochemistry, and physiology of fat digestion held from September 16-20, 2013. The workshop covered 7 themes:
1) Controlled fat digestion and implications of fat in food
2) Biophysics of fat digestion
3) Controlling fat digestion and modeling fat digestion
4) In vitro modeling of digestive processes
5) Bioaccessibility and pharmacokinetics of non-triglyceride lipids
6) Cholesterol, a functional lipid
7) Designed food structures: Targets and Approaches
Each day consisted of lectures and sessions on the different themes with chairs and moderators leading the discussions.
8th National Pharmacy R&D Conference 2014Hasnain Zafar
The document outlines the program for a national pharmacy conference held from June 8-12, 2014. It details the schedule of events which includes workshops, presentations, plenary sessions, exhibitions and social events. On the first day, workshops will be held on topics such as pharmacy practice research, social media for research, and medical statistics. The main conference runs from June 10-12 with keynote speeches, oral and poster presentations on clinical pharmacy, pharmacy practice and other topics. Presentations are divided into sessions and special guest speakers will give plenary talks. Social events include welcome dinner, lunch symposiums and a gala dinner. The conference aims to promote quality research and discussions to improve patient and health system outcomes.
Klose lymphedema conference 2011 faculty and programklosetraining
We are honored to present Prof. Ethel Földi, MD as our Keynote Speaker. Prof. Földi is an internationally recognized authority on clinical lymphedema and lymphatic disorders. She serves as the Medical Director at the world-renowned Földi Clinic, specializing in the diagnosis and treatment of patients with lymphedema. Currently, Prof. Földi is the president of the Society of German-speaking lymphologists and a member of the International Advisory Committee to the National Lymphedema Network (NLN). She is also a past-President of the International Society of Lymphology (ISL).
This document outlines the program for a two-day cell therapy conference with sessions on various applications of cell therapy including for heart disease, bone repair, immunotherapy, and drug discovery. Day 1 consists of sessions on cell therapy for heart disease, bone repair, and immunotherapy. Day 2 covers stem cells for drug discovery and roundtable discussions on business models and regulations in cell therapy. The program includes over 30 speaker presentations and poster sessions.
This document provides details on the organization of the 109th anniversary event of the Faculty of Medicine at Unair University. It will include 4 episodes discussing topics like healthcare entrepreneurship, international research collaboration, and medical tourism in Indonesia. Episodes will feature international and local speakers as well as panel discussions. The event will utilize a hybrid format with some speakers and attendees online and others offline. Precise schedules, speakers, and logistical details are provided for each episode. The budget outlines costs for coordination, speaker and moderator honorariums, venue, catering, and other expenses totaling over 173 million rupiah.
The document provides information about the 10th annual conference of the International Society for Pelviperineology (ISPP) being held from October 10-13, 2013 in Sydney, Australia. The conference will feature international and local speakers covering the latest developments in pelvic medicine and surgery. Events include advanced surgical skills workshops, debates, and presentations on topics such as pelvic organ prolapse, urinary incontinence, and fistula repair. Social events include a welcome reception, gala dinner with views of Sydney Harbour, and a Sydney Harbour cruise with luncheon. A post-conference cadaver workshop will also be held.
Workshop "Biomedical technologies at Skokovo. Opportunities and challenges"igorod
This document provides the preliminary program for the "Biomedical technologies at Skokovo. Opportunities and challenges" workshop being held on February 1-2, 2011 at the Ritz Carlton in Moscow. The workshop will consist of 5 sessions over the two days covering topics such as opportunities and challenges in biomedical technologies, interdisciplinary research, platform technologies, systems medicine, and moving biomedical research forward. Presentations will be given by over 30 professors and researchers from Russia, the United States, the United Kingdom, Germany, and Canada. The workshop will conclude with a round table discussion moderated by Chris Janssen.
8º Conferencia Internacional de Avances en Osteopatia Medicaguestac667c
This document provides the conference program for the 8th International Conference on Advances in Osteopathic Medicine hosted by the British College of Osteopathic Medicine in Milan, Italy from April 23rd to 25th, 2010. The conference includes oral presentations over three days on topics related to osteopathic research, treatment, and education. It also includes poster sessions, plenary sessions, and a conference dinner. Presentations will be organized into sessions led by chairs and will cover research on osteopathic treatments for various musculoskeletal conditions and systemic issues.
Similar to Final Agenda Workshop Dg Research Ec Sys Med (20)
1. Bio-Modeling Systems is a French company that uses its proprietary CADITM Discovery platform to generate mechanistic models of diseases and their underlying biological mechanisms.
2. The company was founded in 2004 and has since led collaborations resulting in two therapeutic spin-offs in clinical trials and publications in peer-reviewed journals.
3. CADITM Discovery integrates human and artificial intelligence to address the complexity of biological mechanisms and unreliability of scientific publications in a novel discovery paradigm.
This document summarizes information about biopharma industry competitiveness in France. It discusses France's strengths in the biopharma sector including its ranking as the top region in Europe for pharmaceuticals, medtech, and public-sector research. It profiles the organization Adebiotech which is France's independent multidisciplinary biotechnology think-tank and represents various industrial and academic members. It also summarizes projects from companies in France including Bio-Modeling Systems, Pherecydes Pharma, Clean Cells, and their roles in developing novel therapies, conducting clinical trials, and manufacturing biopharmaceutical products.
Andrew Lloyd & Associates, an international PR group, has partnered with Adebiotech, a French think-tank for biotechnology, to promote interdisciplinary innovation in biotech. ALA will help raise Adebiotech's profile and support its growth through public relations activities. Adebiotech leads working groups and conferences on emerging biotech issues involving public and private organizations. The partnership will allow both organizations to increase their visibility and engage with each other's networks in the biotech sector.
1) France's independent multidisciplinary biotechnology think-tank, Adebiotech, promotes interactions between industrial and academic fields to foster sustainable innovations in biotechnology.
2) Adebiotech works across various biotechnology areas like health, environment, food, and industry to create synergies and overcome innovation challenges.
3) Adebiotech's missions include breaking down barriers between disciplines, supporting existing industries, creating new industries, and facilitating dialogue between public and private sectors.
Pherecydes Pharma has launched the Phagoburn clinical trial, the first international clinical study to evaluate the effectiveness of phage therapy in treating serious bacterial infections in burn victims. The randomized, controlled trial will involve 220 patients across 11 hospitals in France, Switzerland, and Belgium. If shown to be safe and effective, phage therapy could provide an alternative or supplement to antibiotics for treating antibiotic-resistant infections.
1) Current in vitro skin safety testing methods have limitations in reliably predicting physiological responses to complex products like natural extracts.
2) Heuristic modelling using CADI can help bridge the gap between in vitro tests and in vivo responses by developing non-linear mechanistic models without assuming functional linearity.
3) CADI models contain elements never described but consistent with current knowledge and can predict experimental modifications, helping validate methods and bypass animal testing.
IMPORTANT: If you want to get a clear review of the Differences & Complementarities Between « Heuristic » and « Mathematical » approaches, we invite you to download our presentation given during the EPA (European Psychiatric Association) conference in 2011 that is now utilized in training programs.
This document discusses Bio-Modeling Systems' (BMS) approach to integrative systems biology modeling called CADI (Computer Assisted Deductive Integration). CADI models are descriptive in-silico models of biological systems and diseases that can explain nonlinear mechanisms and identify new discoveries. The CADI approach applies 5 principles: an architectural approach, a negative selection process, a 4 step validation process, expertise across life sciences and IT, and synergic collaboration. BMS acts as an architect to generate hypotheses that are tested by experimentalists, with the goal of building solid and useful biological models.
1. Bio-Modeling Systems (BMS) is a biotech company that creates CADI models to accelerate life sciences research and discoveries for clients.
2. CADI models are detailed maps of inter-cellular and intra-cellular mechanisms associated with biological states that can describe disease processes without using mathematics.
3. BMS generates revenue by applying CADI models to research programs for pharmaceutical, biotech, chemical and other industries, helping to identify new targets, biomarkers, and therapeutic strategies more quickly and at lower cost.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Final Agenda Workshop Dg Research Ec Sys Med
1. WWOORRKKSSHHOOPP ""FFrroomm SSyysstteemmss BBiioollooggyy ttoo SSyysstteemmss MMeeddiicciinnee""
1144--1155 JJuunnee 22001100
RRuuee dduu CChhaammppss ddee MMaarrss,, 2211
BB--11005500 BBrruusssseellss
BBuuiillddiinngg CCDDMMAA,, MMeeeettiinngg rroooomm --11//SSDDRR22
OOrrggaanniizzeedd bbyy tthhee EEuurrooppeeaann CCoommmmiissssiioonn,, DDGG RReesseeaarrcchh
DDiirreeccttoorraattee ooff HHeeaalltthh,, uunniitt FF..55
Agenda
Monday, 14 June 2010
09:00 Arrival and registration of participants- Coffee
10:00 Welcome and Introduction
10:05 Welcome & introduction
Dr Arnd Hoeveler, Head of unit F5- Health Biotechnology (10 mins)
10:15 Objectives of the Workshop
Dr Christina Kyriakopoulou, Scientific officer in the area of Systems Biology (10 mins)
10.30 Session 1- State-of-the-Art of Systems Biology applications in Medicine:
How systems biology approaches can realistically contribute to medicine and clinical
applications, in the short, medium and long term
The Definition of Systems Medicine?
Chair: Dr Adriano Henney
10:30 Introductory presentation including preliminary analysis of the questionnaires' response
by Chair, Dr Adriano Henney (20 mins)
10.50 Selected presentations of success stories of systems biology for the direct benefit to medicine
(10 mins each)
10:50 “Systems biology approach to the personalization of cancer chronotherapeutics”, Prof. Francis Levi
11:00 “Modelling approaches for understanding of the mechanisms of pathogenesis and disease progression of
Creutzfeld-Jakob disease”, Dr. Francois Iris
11:10 “Systems Approaches to Parkinson’s Disease”, Prof. Peter Wellstead
11:20 Discussion on session 1
12:30 - 13.30 Lunch Break
13:30 Session 2- Analysis of Systems Biology/Systems Medicine Landscape:
Analysis on the strengths, weaknesses, opportunities and in particular on the bottlenecks for systems
medicine to become a reality in Europe
Chairs: Prof. Olaf Wolkenhauer, Prof. Walter Kolch
13:30 Introductory presentation including preliminary analysis of the questionnaires' response
by Chair, Prof. Olaf Wolkenhauer (20 mins)
13:50 "Technologies for systems medicine" by chair, Prof. Walter Kolch (10 mins)
2. 14:00 Discussion on session 2
15:30 – 16.00 Coffee Break
16:00 Continued discussion on session 2
17:30 End of session 2
20:00 Dinner (at your own expenses)
Tuesday, 15 June 2010
09:00 Session 3- The Way Forward:
Priorities for strategic scientific & policy areas to be addressed through European
collaboration in systems medicine in short, medium, long term
Chairs: Prof. David Harrison, Dr Adriano Henney
09:00 Introductory presentation including preliminary analysis of the questionnaires' response
by Chair, Prof. David Harrison (20 mins)
09:20 Discussion on session 3
10:30 – 11.00 Coffee Break
11:00 Continued discussion on session 3
12:30 - 13.30 Lunch Break
13:30 Session 4- Funding bodies' discussion
Description of Systems biology activities by EC and representatives of National Funding agencies
Chairs: Dr Arnd Hoeveler-Head of unit, Dr Bernard Mulligan- Deputy Head of unit
13:30 "Health Collaborative research: Funding mechanisms", Dr Arnd Hoeveler (10 min)
13:40 "Results of the last Systems Biology call-Lessons to learn", Dr Bernard Mulligan (10 min)
13:50 “System biology initiatives for medical applications", Dr Hella Lichtenberg, representative of BMBF (10 min)
14:00 “System biology funding", Dr Tom Foulkes, MRC representative (10 min)
14:10 "A bridge between biology and medicine": Institute of Systems Biology in Luxembourg (LCSB), Prof. Rudi
Balling (5 min)
14:20 Discussion on session 4
15:00 – 15.30 Coffee Break
15:30-16:30 Summarized conclusions of sessions 1,2,3,4 by session chairs (Adriano Henney, Walter Kolch,
David Harrison)
Workshop follow-up- Publication of executive summary recommendations (Bernard Mulligan,
Christina Kyriakopoulou)
16:30 End of workshop